News

Business
General
Money
Personal Money
Funds
Insurance
Taxes
Trading
Investment

UPDATE 2-Clovis Oncology's Rubraca data sets stage for label expansion


June 19 (Reuters) - Positive data on Clovis Oncology Inc's ovarian cancer drug, Rubraca, from a late-stage study could help the U.S. biotech widen the use of the therapy and differentiate it against rivals, the company said on Monday.

Tags:
Source:  http://feeds.reuters.com/~r/reuters/companyNews/~3/6Ydb48rCH6I/clovis-study-idUSL3N1JG2TI


More news:
August - 2017
MoTuWeThFrSaSu
 123456
78910111213
14151617181920
21222324252627
28293031   
September - 2017
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
252627282930 
October - 2017
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031